semaglutide vs dulaglutide GI risks similar between dulaglutide, tirzepatide and Cardiovascular outcomes of semaglutide and

Epigallocatechin gallate (EGCG), an inhibitor of GLUD1 and 2, suppresses the proliferation of neuroblastoma, glioma, and CRC cells 49

Some studies link GLP-1 use to an increased risk for ocular diseases such as nonarteritic anterior ischemic optic neuropathy (NAION), diabetic retinopathy, papillitis, and optic nerve disorders

Jang, W

Effect of lipopolysaccharide on inflammation and insulin action in human muscle

Online GLP-1 services sell access to medication

TMRCP may be another metric to define the clinical meaningfulness of C-peptide, meaning it could be an alternative endpoint to consider for future DMT trials